Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 26Breast Neoplasms 5Leiomyoma 3Neoplasms 2Sleep Wake Disorders 1Sarcopenia 1Prostatectomy 1Polycystic Ovary Syndrome 1Pelvic Pain 1Osteoporosis 1Neoplasm Metastasis 1Kallmann Syndrome 1Hypogonadism 1Hyperprolactinemia 1Highly Endocrine Responsive Operable Breast Cancer 1Hemorrhage 1Fatigue 1Endometriosis 1Cardiovascular Diseases 1Breast Neoplasms, Male 1Advanced Prostate Cancer 1Adenomyosis 1

Interventions

Metformin 91Clomiphene 31Letrozole 23Inositol 19Folic Acid 11Chorionic Gonadotropin 11Exercise 10High-Intensity Interval Training 9drospirenone and ethinyl estradiol combination 8Ethinyl Estradiol 8Contraceptives, Oral 8Cholecalciferol 8cetrorelix 7Tablets 7Progesterone 7Menotropins 6follitropin alfa 5Pioglitazone 5Liraglutide 5Exenatide 5Cyproterone Acetate 5Caloric Restriction 5Vitamin D 4Triptorelin Pamoate 4Surveys and Questionnaires 4Sugars 4Spironolactone 4Glycoprotein Hormones, alpha Subunit 4Fish Oils 4Estradiol 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Polycystic Ovary Syndrome × Gonadotropin-Releasing Hormone × Clear all
NCT00914823 2024-07-31

Kisspeptin Administration in the Adult

Massachusetts General Hospital

Phase 1 Completed
256 enrolled

Hyperprolactinemia, Hypogonadism, Polycystic Ovary Syndrome, Kallmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡